These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30160214)

  • 21. Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment.
    Zhao X; Chen M; Huang B; Ji H; Yuan M
    Int J Mol Sci; 2011; 12(10):7022-37. PubMed ID: 22072933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design of 2-Nitroimidazooxazine Derivatives as Deazaflavin-Dependent Nitroreductase (Ddn) Activators as Anti-Mycobacterial Agents Based on 3D QSAR, HQSAR, and Docking Study with In Silico Prediction of Activity and Toxicity.
    Gupta N; Vyas VK; Patel BD; Ghate M
    Interdiscip Sci; 2019 Jun; 11(2):191-205. PubMed ID: 28895050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments.
    Pandey G; Saxena AK
    J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An explorative study on potent Gram-negative specific LpxC inhibitors: CoMFA, CoMSIA, HQSAR and molecular docking.
    Shiri F; Salahinejad M; Dijoor R; Nejati-Yazdinejad M
    J Recept Signal Transduct Res; 2018 Apr; 38(2):151-165. PubMed ID: 29623756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3D-QSAR (CoMFA, CoMSIA) and Molecular Docking Studies on Histone Deacetylase 1 Selective Inhibitors.
    Abdizadeh T; Ghodsi R; Hadizadeh F
    Recent Pat Anticancer Drug Discov; 2017 Nov; 12(4):365-383. PubMed ID: 28482791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.
    Zheng M; Yu K; Liu H; Luo X; Chen K; Zhu W; Jiang H
    J Comput Aided Mol Des; 2006 Sep; 20(9):549-66. PubMed ID: 17103017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of novel dopamine D
    Zhang C; Li Q; Meng L; Ren Y
    J Biomol Struct Dyn; 2020 Feb; 38(3):860-885. PubMed ID: 30916624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insight into the interactions between novel isoquinolin-1,3-dione derivatives and cyclin-dependent kinase 4 combining QSAR and molecular docking.
    Zheng J; Kong H; Wilson JM; Guo J; Chang Y; Yang M; Xiao G; Sun P
    PLoS One; 2014; 9(4):e93704. PubMed ID: 24722522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 3D-QSAR analysis of a series of S-DABO derivatives as anti-HIV agents by CoMFA and CoMSIA.
    Xu HR; Fu L; Zhan P; Liu XY
    SAR QSAR Environ Res; 2016 Dec; 27(12):999-1014. PubMed ID: 27667445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CoMFA and CoMSIA 3D-QSAR analysis of diaryloxy-methano-phenanthrene derivatives as anti-tubercular agents.
    Shagufta ; Kumar A; Panda G; Siddiqi MI
    J Mol Model; 2007 Jan; 13(1):99-109. PubMed ID: 16858589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
    Sethi KK; Verma SM
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Research for Quinazoline-2,4-diones as HPPD Inhibitors Based on 2D-MLR and 3D-QSAR Models.
    Fu Y; Sun YN; Cao HF; Yi KH; Zhao LX; Li JZ; Ye F
    Comb Chem High Throughput Screen; 2017; 20(9):748-759. PubMed ID: 28637410
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Shirvani P; Fassihi A
    J Biomol Struct Dyn; 2022 Aug; 40(13):5965-5982. PubMed ID: 33475043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 3D-QSAR studies on triazolopiperazine amide inhibitors of dipeptidyl peptidase-IV as anti-diabetic agents.
    Saqib U; Siddiqi MI
    SAR QSAR Environ Res; 2009 Jul; 20(5-6):519-35. PubMed ID: 19916112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
    Gade S; Mahmood S
    J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors.
    Zięba A; Laitinen T; Patel JZ; Poso A; Kaczor AA
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34204026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In silico QSAR studies of anilinoquinolines as EGFR inhibitors.
    Pasha FA; Muddassar M; Srivastava AK; Cho SJ
    J Mol Model; 2010 Feb; 16(2):263-77. PubMed ID: 19590909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CoMFA and CoMSIA studies on C-aryl glucoside SGLT2 inhibitors as potential anti-diabetic agents.
    Vyas VK; Bhatt HG; Patel PK; Jalu J; Chintha C; Gupta N; Ghate M
    SAR QSAR Environ Res; 2013; 24(7):519-51. PubMed ID: 23305412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) and molecular docking study of thienopyrimidine and thienopyridine derivatives to explore structural requirements for aurora-B kinase inhibition.
    Borisa A; Bhatt H
    Eur J Pharm Sci; 2015 Nov; 79():1-12. PubMed ID: 26343315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3D QSAR studies on T-type calcium channel blockers using CoMFA and CoMSIA.
    Doddareddy MR; Jung HK; Cha JH; Cho YS; Koh HY; Chang MH; Pae AN
    Bioorg Med Chem; 2004 Apr; 12(7):1613-21. PubMed ID: 15028254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.